Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.500
-0.004 (-0.75%)
Nov 21, 2024, 1:22 PM EST - Market open
Renovaro Employees
Renovaro had 25 employees as of June 30, 2024. The number of employees increased by 13 or 108.33% compared to the previous year.
Employees
25
Change (1Y)
13
Growth (1Y)
108.33%
Revenue / Employee
n/a
Profits / Employee
-$4,627,487
Market Cap
79.25M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Inotiv | 2,055 |
| P3 Health Partners | 400 |
| MDxHealth | 300 |
| OptimizeRx | 136 |
| BioAtla | 65 |
| Aerovate Therapeutics | 51 |
| ESSA Pharma | 50 |
| Werewolf Therapeutics | 47 |
RENB News
- 17 days ago - Renovaro Issues Shareholder Letter and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing - GlobeNewsWire
- 5 weeks ago - Renovaro Announces Strategic Restructuring and Leadership Transition - GlobeNewsWire
- 2 months ago - RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress - GlobeNewsWire
- 2 months ago - RenovaroCube Announces Strategic Offering of Up to 20% Ownership - GlobeNewsWire
- 5 months ago - Renovaro, Inc. Announces $10 million in Equity Committed - GlobeNewsWire
- 6 months ago - Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy - GlobeNewsWire
- 6 months ago - Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Renovaro (NASDAQ:RENB) - Benzinga